Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
NCT06956755 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6990
Last updated 2025-05-06
Summary
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Conditions
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Acute
Sponsors & Collaborators
-
Groupe Francophone des Myelodysplasies
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-07
- Primary Completion
- 2030-01-05
- Completion
- 2031-01-05
Countries
- France
Study Locations
More Related Trials
-
Cohort Study Assessing the Treatment Strategy for High-Risk Myelodysplastic Syndromes in Patients Under 70
NCT05367583 ·Status: UNKNOWN
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy
NCT01235572 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Mechanisms of Resistance to Azacitidine
NCT01210274 ·Status: RECRUITING
-
The National Myelodysplastic Syndromes (MDS) Study
NCT02775383 ·Status: COMPLETED
-
Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia
NCT03439371 ·Status: RECRUITING ·Phase: NA
-
A Phase II Study of Maintenance With Azacitidine in MDS Patients
NCT00446303 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00002517 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
NCT04587856 ·Status: RECRUITING ·Phase: NA
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
NCT04460950 ·Status: RECRUITING
-
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
NCT02084563 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples
NCT04251078 ·Status: RECRUITING
-
Role of BMP Pathway in MDS Progression
NCT06175923 ·Status: NOT_YET_RECRUITING
-
AML-MDS Novel Prognostic Tests Clinical Study
NCT01685619 ·Status: COMPLETED
-
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care
NCT04212390 ·Status: COMPLETED
-
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia
NCT01385787 ·Status: COMPLETED
-
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT00003790 ·Status: COMPLETED
-
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
NCT05558943 ·Status: NOT_YET_RECRUITING
-
Registry on Hypomethylating Agents in Myeloid Neoplasms
NCT01595295 ·Status: COMPLETED
-
Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
NCT00986804 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases
NCT03959007 ·Status: COMPLETED ·Phase: NA
-
Observational Study Towards the Impact of Newly Started Treatment in MDS on QoL
NCT04053933 ·Status: COMPLETED
-
Clinical and Genomic Registry of MDS in Asia
NCT03169296 ·Status: UNKNOWN
-
High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)
NCT03217903 ·Status: UNKNOWN ·Phase: NA